G-Protein Coupled Receptors (GPCRs)

G-Protein Coupled Receptors (GPCRs)

Global G-Protein Coupled Receptors (GPCRs) Market to Reach $3.9 Billion by 2027
In the changed post COVID-19 business landscape, the global market for G-Protein Coupled Receptors (GPCRs) estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$3.9 Billion by 2027, growing at a CAGR of 5.7% over the analysis period 2020-2027. Cell Lines, one of the segments analyzed in the report, is projected to record a 5.6% CAGR and reach US$1.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Detection Kits segment is readjusted to a revised 6.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $974.6 Million, While China is Forecast to Grow at 8.4% CAGR
The G-Protein Coupled Receptors (GPCRs) market in the U.S. is estimated at US$974.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$318.7 Million by the year 2027 trailing a CAGR of 8.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.Cell Culture Reagents Segment to Record 5% CAGR
In the global Cell Culture Reagents segment, USA, Canada, Japan, China and Europe will drive the 5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$370.6 Million in the year 2020 will reach a projected size of US$518.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 52 Featured) -

  • Abcam plc
  • Addex Pharmaceuticals Ltd.
  • Arena Pharmaceuticals Inc.
  • Becton-Dickinson and Company
  • Eurofins DiscoverX Corporation
  • HD Biosciences Co., Ltd
  • Merck KGaA
  • Perkin Elmer Inc
  • Promega Corporation
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Influencer Market Insights
World Market Trajectories
G-Protein Coupled Receptors (GPCRs) – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
GPCR: An Introduction
Important Role of GPCRs in Drug Discovery
Popular Types of GPCRs of Therapeutic Interest
Classification of GPCRs
Orphan GPCRs: A Promising Area for Drug Discovery
GPCR Signaling Pathways
Physiological Roles Performed by GPCRs
Outlook
Geographic Market Analysis
Challenges
Competition
Recent Market Activity
World Brands
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Therapeutic Potential of GPCRs Gains Wide Recognition
Allosteric Modulators and Implication of Allostery in Drug Discovery
GPCRs Registered as Targets for Approved Drugs with EMBL-CHEMBL, IUPHAR, and The DrugBank
GPCRs Registered as Targets for Approved Drugs with EMBL-CHEMBL
GPCRs Registered as Targets for Approved Drugs with International Union of Basic and Clinical Pharmacology (IUPHAR)
GPCRs Registered as Targets for Approved Drugs with The DrugBank
FDA Approved GPCR Targeting Drugs (Excl. Diagnostic Agents) for the Period 2015-2019
Hurdles Faced…
Developments in Structural Biology and Receptor Pharmacology Offer Novel Opportunities to GPCR Drug Discovery
In Silico Approaches Underway for GPCR Drug Screening
Microfluidic Cell Technology Holds Potential
Pipeline GPCR Drug Candidates Widen Prospects
Select GPCR Small Molecule Drugs in Active Clinical Development
GPCR Ligands (Agonist) in Phase III Clinical Development
GPCR Ligands (Antagonist) in Phase III Clinical Development
New Indications to Aid Growth
CRISPR Holds Potential to Speed Up GPCR-based Drug Discovery
GPCR-targeted Drugs and Role in Cancer Treatment
Select FDA Approved Drugs and Antibodies against Various Cancer Types
Potential GPCR targets for Cancer Treatment
Anti GPCRs Drugs and Antibodies under Clinical Trials
Rising Incidence of Cancer to Drive Drives Opportunities
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
GPCRs Evolve as Important targets for developing novel therapeutics for Neurodegerative Disorders
Number of Individuals Suffering from Alzheimer's in the US: 2020 and 2025
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
GPCRs: An Important Target for Cardiovascular Drugs
Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
GPCR Screening and Targeting Technologies
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for G-Protein Coupled Receptors (GPCRs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 3: World 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 6: World 12-Year Perspective for Cell Lines by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Detection Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Detection Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 9: World 12-Year Perspective for Detection Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Cell Culture Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Cell Culture Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 12: World 12-Year Perspective for Cell Culture Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Ligands by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Ligands by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 15: World 12-Year Perspective for Ligands by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for cAMP Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for cAMP Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 18: World 12-Year Perspective for cAMP Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Calcium Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Calcium Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 21: World 12-Year Perspective for Calcium Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for ß-Arrestin Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for ß-Arrestin Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 24: World 12-Year Perspective for ß-Arrestin Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 25: World Recent Past, Current & Future Analysis for Radioligand Binding & GTPyS Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Radioligand Binding & GTPyS Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 27: World 12-Year Perspective for Radioligand Binding & GTPyS Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 28: World Recent Past, Current & Future Analysis for Internalization Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for Internalization Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 30: World 12-Year Perspective for Internalization Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 31: World Recent Past, Current & Future Analysis for Other Assay Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 32: World Historic Review for Other Assay Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 33: World 12-Year Perspective for Other Assay Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 34: World Recent Past, Current & Future Analysis for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 35: World Historic Review for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 36: World 12-Year Perspective for Cancer Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 37: World Recent Past, Current & Future Analysis for Metabolic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 38: World Historic Review for Metabolic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 39: World 12-Year Perspective for Metabolic Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 40: World Recent Past, Current & Future Analysis for Inflammation Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 41: World Historic Review for Inflammation Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 42: World 12-Year Perspective for Inflammation Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 43: World Recent Past, Current & Future Analysis for CNS Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 44: World Historic Review for CNS Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 45: World 12-Year Perspective for CNS Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 46: World Recent Past, Current & Future Analysis for Respiratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 47: World Historic Review for Respiratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 48: World 12-Year Perspective for Respiratory Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 49: World Recent Past, Current & Future Analysis for Cardiovascular Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 50: World Historic Review for Cardiovascular Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 51: World 12-Year Perspective for Cardiovascular Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
TABLE 52: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 53: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 54: World 12-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 55: USA Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: USA Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 57: USA 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2021 & 2027
TABLE 58: USA Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: USA Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 60: USA 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2021 & 2027
TABLE 61: USA Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: USA Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 63: USA 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2021 & 2027
CANADA
TABLE 64: Canada Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: Canada Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 66: Canada 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2021 & 2027
TABLE 67: Canada Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Canada Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 69: Canada 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2021 & 2027
TABLE 70: Canada Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Canada Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 72: Canada 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2021 & 2027
JAPAN
G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 73: Japan Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: Japan Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 75: Japan 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2021 & 2027
TABLE 76: Japan Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: Japan Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 78: Japan 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2021 & 2027
TABLE 79: Japan Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: Japan Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 81: Japan 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2021 & 2027
CHINA
G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 82: China Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: China Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 84: China 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2021 & 2027
TABLE 85: China Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: China Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 87: China 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2021 & 2027
TABLE 88: China Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: China Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 90: China 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2021 & 2027
EUROPE
G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 91: Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 92: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 93: Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2021 & 2027
TABLE 94: Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 96: Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2021 & 2027
TABLE 97: Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 99: Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2021 & 2027
TABLE 100: Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 101: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 102: Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2021 & 2027
FRANCE
G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 103: France Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 104: France Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 105: France 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2021 & 2027
TABLE 106: France Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: France Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 108: France 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2021 & 2027
TABLE 109: France Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 110: France Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 111: France 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2021 & 2027
GERMANY
G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 112: Germany Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: Germany Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 114: Germany 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2021 & 2027
TABLE 115: Germany Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 116: Germany Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 117: Germany 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2021 & 2027
TABLE 118: Germany Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: Germany Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 120: Germany 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2021 & 2027
ITALY
TABLE 121: Italy Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 122: Italy Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 123: Italy 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2021 & 2027
TABLE 124: Italy Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 125: Italy Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 126: Italy 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2021 & 2027
TABLE 127: Italy Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 128: Italy Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 129: Italy 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2021 & 2027
UNITED KINGDOM
G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 130: UK Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 131: UK Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 132: UK 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2021 & 2027
TABLE 133: UK Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 134: UK Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 135: UK 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2021 & 2027
TABLE 136: UK Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 137: UK Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 138: UK 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2021 & 2027
REST OF EUROPE
TABLE 139: Rest of Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 140: Rest of Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 141: Rest of Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2021 & 2027
TABLE 142: Rest of Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 143: Rest of Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 144: Rest of Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2021 & 2027
TABLE 145: Rest of Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 146: Rest of Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 147: Rest of Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2021 & 2027
ASIA-PACIFIC
G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 148: Asia-Pacific Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 149: Asia-Pacific Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 150: Asia-Pacific 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2021 & 2027
TABLE 151: Asia-Pacific Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 152: Asia-Pacific Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 153: Asia-Pacific 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2021 & 2027
TABLE 154: Asia-Pacific Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 155: Asia-Pacific Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 156: Asia-Pacific 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2021 & 2027
REST OF WORLD
TABLE 157: Rest of World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 158: Rest of World Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 159: Rest of World 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2021 & 2027
TABLE 160: Rest of World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 161: Rest of World Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 162: Rest of World 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2021 & 2027
TABLE 163: Rest of World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 164: Rest of World Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 165: Rest of World 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 52

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings